BACTROBAN Drug Patent Profile
✉ Email this page to a colleague
When do Bactroban patents expire, and when can generic versions of Bactroban launch?
Bactroban is a drug marketed by Glaxosmithkline and is included in three NDAs.
The generic ingredient in BACTROBAN is mupirocin. There are sixteen drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Bactroban
A generic version of BACTROBAN was approved as mupirocin by PADAGIS ISRAEL on November 7th, 2003.
Summary for BACTROBAN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 87 |
Clinical Trials: | 19 |
Patent Applications: | 4,627 |
Drug Prices: | Drug price information for BACTROBAN |
What excipients (inactive ingredients) are in BACTROBAN? | BACTROBAN excipients list |
DailyMed Link: | BACTROBAN at DailyMed |
Recent Clinical Trials for BACTROBAN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Lindenhofgruppe AG | Phase 4 |
Lindenhof AG | Phase 4 |
National Jewish Health | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for BACTROBAN
US Patents and Regulatory Information for BACTROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Glaxosmithkline | BACTROBAN | mupirocin | OINTMENT;TOPICAL | 050591-001 | Dec 31, 1987 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BACTROBAN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Glaxosmithkline | BACTROBAN | mupirocin calcium | OINTMENT;NASAL | 050703-001 | Sep 18, 1995 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
Glaxosmithkline | BACTROBAN | mupirocin calcium | CREAM;TOPICAL | 050746-001 | Dec 11, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for BACTROBAN
See the table below for patents covering BACTROBAN around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
African Regional IP Organization (ARIPO) | 608 | Pharmaceutical or veterinary composition comprising a cream base. | ⤷ Try a Trial |
South Korea | 930002509 | ⤷ Try a Trial | |
Yugoslavia | 45724 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |